Factor Xa Inhibitors

Preferred Label : Factor Xa Inhibitors;

MeSH definition : Endogenous factors and drugs that inhibit or block the activity of FACTOR XA.;

MeSH synonym : Factor Xa Inhibitor; Inhibitor, Factor Xa; Xa Inhibitor, Factor;

CISMeF synonym : Direct Factor Xa Inhibitors; Inhibitors, Factor Xa;

MeSH hyponym : Direct-Acting Oral Anticoagulants; Anticoagulants, Direct-Acting Oral; Direct Acting Oral Anticoagulants; Oral Anticoagulants, Direct-Acting; Direct Factor Xa Inhibitor; Direct-Acting Oral Anticoagulant; Anticoagulant, Direct-Acting Oral; Direct Acting Oral Anticoagulant; Oral Anticoagulant, Direct-Acting;

Wikipedia link : https://en.wikipedia.org/wiki/Direct-acting oral anticoagulants;

Is substance : O;

Details

Origin ID

D065427;

UMLS CUI

C3669283;

ATC code(s)
- Direct factor Xa inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Direct Factor Xa Inhibitor [NCIt concept]
- Direct factor Xa inhibitors [ICD-11 Extension code]
- antithrombin III [Blood Transfusion thesaurus concept]
Currated CISMeF NLP mapping
- Factor Xa Inhibitors [LOINC hierarchical part]
MeSH Descriptor(s) used for indexing
- factor xa [MeSH Descriptor]
Record concept(s)
- Direct Factor Xa Inhibitors [MeSH concept]
- Factor Xa Inhibitors [MeSH concept]
See also (suggested by CISMeF)
- factor xa [MeSH Descriptor]
See also inter- (CISMeF)
- Antithrombin [LOINC component]
- Coagulation factor Xa inhibitor (disposition) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one [MeSH Supplementary Concept]
- 1-(1-amino-7-isoquinolyl)-N-(2'-(aminosulfonyl)-1,1'-biphenyl-4-yl)-3-methyl-1H-pyrazole-5-carboxamide [MeSH Supplementary Concept]
- 1-(2,2-difluoroethyl)pyrrolidine-3,4-dicarboxylic acid 3-((5-chloropyridin-2-yl)amide) 4-((2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl)amide) [MeSH Supplementary Concept]
- 1-(3-(aminomethyl)phenyl)-N-(3-fluoro-2'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide [MeSH Supplementary Concept]
- 1-(3-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-6-(2'-(3-hydroxy-N-pyrrolidinyl)methyl-(1,1')-biphen-4-yl)-1,4,5,6-tetrahydropyrazolo-(3,4-c)-pyridin-7-one [MeSH Supplementary Concept]
- 2-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)propanoyl)piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo(1,5-c)imidazol-3-one [MeSH Supplementary Concept]
- 2-(4-(dimethylamino)benzoylamino)-5-methanesulfonylamino-N'-(4-methoxyphenyl)benzamide [MeSH Supplementary Concept]
- 2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide [MeSH Supplementary Concept]
- 2-carbamoyl-4-((6-chloronaphthalen-2-yl)sulfonyl)-1-((5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl)carbonyl)piperazine [MeSH Supplementary Concept]
- 3,3'-(3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy))bis(benzenecarbox(imide)amide) [MeSH Supplementary Concept]
- 3-(4-(5-(2,6-dimethylpiperidin-1-yl)pentyl)-3-oxo-3,4-dihydroxyquinoxalin-2-yl)benzamidine [MeSH Supplementary Concept]
- 3-(4-(5-(2,6-dimethyltetrahydro-1(2H)-pyridinyl)pentyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-benzenecarboximidamide [MeSH Supplementary Concept]
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-(((4,5-dihydro-2-oxazolyl)methylamino)methyl)-2-thiophenecarboxamide [MeSH Supplementary Concept]
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-((methylamino)methyl)-2-thiophenecarboxamide [MeSH Supplementary Concept]
- 4-((2-amidino-1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl)-1-(4-pyridinyl)piperidine-4-carboxylic acid monomethanesulfonate trihydrate [MeSH Supplementary Concept]
- 5-chlorothiophene-2-carboxylic acid (2-(2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)amide [MeSH Supplementary Concept]
- 6-(dimethylcarbamoyl)nicotinoyl guanidine [MeSH Supplementary Concept]
- 6-chloromethyl-3-(2,5-dichlorophenoxycarbonyl)-2-benzopyrone [MeSH Supplementary Concept]
- Amblyomin-X protein, amblyomma cajennense [MeSH Supplementary Concept]
- BMS 269223 [MeSH Supplementary Concept]
- BnSO(2)-D-Arg-Gly-Arg-ketothiazole [MeSH Supplementary Concept]
- DPC 602 [MeSH Supplementary Concept]
- FX 2212 [MeSH Supplementary Concept]
- Fondaparinux [MeSH Descriptor]
- ITF 1331 [MeSH Supplementary Concept]
- N(2)-(4-(dimethylamino)benzoyl)-4-hydroxy-N(1)-(4-methoxybenzoyl)-1,2-benzenediamine [MeSH Supplementary Concept]
- N-(4-(1-(acetimidoyl)piperidin-4-yloxy)-3-carbamoylphenyl)-N-(3-(3-amidinophenyl)-2-fluoro-2-propenyl)sulfamoylacetic acid [MeSH Supplementary Concept]
- N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide [MeSH Supplementary Concept]
- PD0313052 [MeSH Supplementary Concept]
- RPR 120844 [MeSH Supplementary Concept]
- RPR 130737 [MeSH Supplementary Concept]
- RPR 208566 [MeSH Supplementary Concept]
- RPR 209685 [MeSH Supplementary Concept]
- RWJ 445167 [MeSH Supplementary Concept]
- Rivaroxaban [MeSH Descriptor]
- SE 170 [MeSH Supplementary Concept]
- SEL 2711 [MeSH Supplementary Concept]
- SF 324 [MeSH Supplementary Concept]
- SV-66 protein, simulium vittatum [MeSH Supplementary Concept]
- WX-FX4 compound [MeSH Supplementary Concept]
- YM 60828 [MeSH Supplementary Concept]
- ZK 805412 [MeSH Supplementary Concept]
- ZK 806299 [MeSH Supplementary Concept]
- alpha-(3-amidinylphenoxy)-2-bromo-N-(5-(pyrrolidin-1-ylcarbonyl)phenyl)phenylacetamide [MeSH Supplementary Concept]
- apixaban [MeSH Supplementary Concept]
- betrixaban [MeSH Supplementary Concept]
- darexaban [MeSH Supplementary Concept]
- edoxaban [MeSH Supplementary Concept]
- eisenstasin [MeSH Supplementary Concept]
- factor xa, Glu-Gly-Arg- [MeSH Supplementary Concept]
- idraparinux [MeSH Supplementary Concept]
- isoleucyl-glutamyl-glycyl-arginine chloromethyl ketone [MeSH Supplementary Concept]
- lefaxin [MeSH Supplementary Concept]
- lipoprotein-associated coagulation inhibitor [MeSH Supplementary Concept]
- lufaxin protein, lutzomyia longipalpis [MeSH Supplementary Concept]
- otamixaban [MeSH Supplementary Concept]
- therostasin protein, theromyzon tessulatum [MeSH Supplementary Concept]
- tick anticoagulant peptide [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Factor Xa Inhibitors [LOINC hierarchical part]
Validated automatic mappings to BTNT
- Direct factor Xa inhibitors [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients